Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/10/2002WO2002079437A2 Transgenic mice containing abc transporter-like aptase gene disruptions
10/10/2002WO2002079434A2 Transgenic mice containing kir3.3 potassium channel gene disruptions
10/10/2002WO2002079420A2 Adam-like protease disruptions, compositions and methods related thereto
10/10/2002WO2002079417A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/10/2002WO2002079415A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079407A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079402A2 Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation
10/10/2002WO2002079401A2 Novel rgs9 protein binding interactions and methods of use thereof
10/10/2002WO2002079398A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002WO2002079397A2 Virus derived antimicrobial peptides
10/10/2002WO2002079393A2 Dynamic action reference tools
10/10/2002WO2002079390A2 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof
10/10/2002WO2002079387A2 Modular molecular clasps and uses thereof
10/10/2002WO2002079386A2 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002WO2002079385A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/10/2002WO2002079384A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079383A2 Fizz1 for metabolism regulation
10/10/2002WO2002079380A2 Disruptions in gaba receptor rh02 subunit, methods adn uses thereof
10/10/2002WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i
10/10/2002WO2002079262A1 Composition for enteral nutrition comprising fibres
10/10/2002WO2002079252A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079247A2 Intimins in the prevention or treatment of infections:ii
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079242A2 Adp-ribosylating bacterial toxins
10/10/2002WO2002079240A2 Intimins for the prevention or treatment of infections: i
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079236A1 Alpha conotoxin peptides with analgesic properties
10/10/2002WO2002079234A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079227A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002078863A1 Generation of pharmaceutical agent particles using focused acoustic energy
10/10/2002WO2002078740A1 Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit ccr5-tropic hiv-1 infection and replication
10/10/2002WO2002078736A2 Antiallergic pharmaceutical composition
10/10/2002WO2002078731A1 Module of pd-1 interactions with its ligands
10/10/2002WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002WO2002078729A1 Compositions and methods for diagnosing or treating psoriasis
10/10/2002WO2002078728A2 Peptides for the treatment of wound contracture
10/10/2002WO2002078715A1 Method for induction of an antigen specific anti-inflammatory response
10/10/2002WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002WO2002078677A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002WO2002078675A2 Particles for inhalation having sustained release properties
10/10/2002WO2002078672A2 Liposomal tumor necrosis factor compositions and methods
10/10/2002WO2002078670A1 Neuroprotectants formulations and methods
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002WO2002078636A2 Detection and treatment of colorectal cancer
10/10/2002WO2002078624A2 Aerosol administration of interleukin-2 liposomes
10/10/2002WO2002078620A2 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
10/10/2002WO2002078619A2 Alkynylated single-strand oligonucleotide and uses thereof
10/10/2002WO2002078618A2 Methods of modulating surfactant production
10/10/2002WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002WO2002078606A2 Thrombospondin-2 and uses thereof
10/10/2002WO2002078600A2 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA
10/10/2002WO2002078599A2 CD8α + LYMPHOID DENDRITIC CELL DIFFERENTIATED FROM HUMAN HEMATOPOIETIC STEM CELL AND A METHOD FOR DIFFERENTIATION
10/10/2002WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078524A2 Translational profiling
10/10/2002WO2002078520A2 IL-1ss INHIBITION FOR MYELOMA AND RELATED DISORDERS
10/10/2002WO2002078516A2 Compositions and methods for the therapy and diagnosis of cancer
10/10/2002WO2002078435A1 Transgenic mice containing gnb1 gene disruptions
10/10/2002WO2002078420A2 Molecules for disease detection and treatment
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002063018A3 Method for the production of plant seed with modified fibre content and modified seed coat
10/10/2002WO2002062828A3 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/10/2002WO2002062212A3 A personal condition management system
10/10/2002WO2002060422A3 Treatment of diabetes mellitus using vardenafil
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002059149A3 Pro-apoptotic proteins and dna molecules encoding them
10/10/2002WO2002058749A3 Carrier with solid fibrinogen and solid thrombin
10/10/2002WO2002058738A3 Use of rad51 inhibitors for p53 gene therapy
10/10/2002WO2002057287A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/10/2002WO2002055111A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
10/10/2002WO2002053734A3 Methods and compositions for inhibiting neoplastic cell growth
10/10/2002WO2002051862A3 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units
10/10/2002WO2002051460A3 Bioactive materials for aneurysm repair
10/10/2002WO2002051390A3 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation
10/10/2002WO2002051386A3 Lipid microparticles by cryogenic micronization
10/10/2002WO2002036753A3 Human triacylglycerol lipase
10/10/2002WO2002034895A3 Novel aggrecanase molecules
10/10/2002WO2002034763A3 Mucin comprising vehicle for the transport of biologically-active agents
10/10/2002WO2002030463A3 Reduced-viscosity concentrated protein formulations
10/10/2002WO2002029045A3 Method for the production of vitamin k-dependent proteins
10/10/2002WO2002029025A3 Factor vii glycoforms
10/10/2002WO2002026820A3 Immunomodulatory protein derived from the yaba monkey tumor virus
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002012336A9 TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
10/10/2002WO2002008389A3 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002002599A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095929A3 Interferon for treatment of multiple sclerosis
10/10/2002WO2001095895A3 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
10/10/2002WO2001094412A9 56201, a novel human sodium ion channel family member and uses thereof
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001074382A9 Method of treatment using ligand-immunogen conjugates
1 ... 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 ... 3163